How they differ

Daily sublingual buprenorphine is taken by the patient, while Sublocade is administered as a long-acting injection in a clinical setting. The injection changes adherence and refill logistics but also requires specific eligibility and administration steps.

Who may consider each option

Some patients may want fewer pharmacy trips or less daily medication handling. Others may need the flexibility of a daily medication plan. A clinician should review stability, dose history, side effects, pregnancy status if relevant, and access.

Safety considerations

Long-acting injections cannot be quickly removed once given. Daily medication requires safe storage and consistent use. Both require clinical monitoring and attention to sedatives, alcohol, and overdose risk.

What to ask your clinician

Ask how each option fits your current opioid exposure, withdrawal risk, medical history, pregnancy status if relevant, other medications, pharmacy access, work or travel schedule, and follow-up needs.

How SuboxoneNYC evaluates medication questions

SuboxoneNYC evaluates medication questions through physician review, secure-video evaluation, and structured follow-up when care is clinically appropriate and legally permitted. Treatment acceptance, prescriptions, medication changes, and outcomes are not guaranteed. For broader context, read Suboxone vs. Methadone vs. Vivitrol, Suboxone Help, How It Works, and the FAQ.

When urgent or emergency care is needed

SuboxoneNYC is not an emergency, urgent-care, detox, hospital, or crisis service. Call 911 or go to the nearest emergency department for overdose risk, severe withdrawal, chest pain, trouble breathing, severe confusion, severe intoxication, suicidality, pregnancy-related medical danger, or immediate danger. Call or text 988 for mental health or substance-use crisis support.

References and clinical sources

  1. SAMHSA: Medications for Substance Use Disorders
  2. NIDA: Medications for Opioid Use Disorder
  3. FDA: Information about Medication-Assisted Treatment
  4. SAMHSA TIP 63: Medications for Opioid Use Disorder